The 57 rating InvestorsObserver gives to Regulus Therapeutics Inc (RGLS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 74 percent of stocks in the Biotechnology industry, RGLS’s 57 overall rating means the stock scores better than 57 percent of all stocks.
RGLS has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on RGLS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Regulus Therapeutics Inc Stock Today?
Regulus Therapeutics Inc (RGLS) stock is lower by -6.72% while the S&P 500 is up 0.39% as of 12:53 PM on Wednesday, Nov 22. RGLS is down -$0.09 from the previous closing price of $1.37 on volume of 99,672 shares. Over the past year the S&P 500 is higher by 13.80% while RGLS is down -22.89%. RGLS lost -$1.59 per share the over the last 12 months.
Click Here to get the full Stock Report for Regulus Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
